Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation

BACKGROUND. The purpose of this study was to identify determinants of renal disease progression in adults with Fabry disease during treatment with agalsidase beta. METHODS. Renal function was evaluated in 151 men and 62 women from the Fabry Registry who received agalsidase beta at an average dose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Warnock, David G., Ortiz, Alberto, Mauer, Michael, Linthorst, Gabor E., Oliveira, João P., Serra, Andreas L., Maródi, László, Mignani, Renzo, Vujkovac, Bojan, Beitner-Johnson, Dana, Lemay, Roberta, Cole, J.Alexander, Svarstad, Einar, Waldek, Stephen, Germain, Dominique P., Wanner, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289896/
https://www.ncbi.nlm.nih.gov/pubmed/21804088
http://dx.doi.org/10.1093/ndt/gfr420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289896/
https://www.ncbi.nlm.nih.gov/pubmed/21804088
http://dx.doi.org/10.1093/ndt/gfr420

Ejemplares similares